semaglutide hfpef trial Therapy for HFpEF: A step forward brings new hope for people with obesity and diabetes STEP HFpEF Sub Studies Whiteboard

Among people eligible for treatment, 33.1% (95% CI, 31.4-34.8), 28.1% (95% CI, 26.4-29.8) and 26.2% (95% CI, 24.6-27.9) met the exclusion criteria for tirzepatide, liraglutide and semaglutide, respectively

Glutathione is your bodys internal antioxidant, and it is made in the liver from the amino acids cysteine, glutamate, and glycine. Contrary to most antioxidants originating from plants, glutathione is a substance that the liver can naturally manufacture

Supplementary Information Additional file 1

Mounjaro (tirzepatide), from Eli Lilly, is a dual-acting GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, and mimick the natural hormone